No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
SOLiD Awarded NTIA Grant for Open RAN Development Project
PepGen Stock Craters 35% on FDA Clinical Hold
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst
Wedbush Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $16
H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $16
HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target